Form 4: Dexcom Director Barbara Kahn Transfers Shares to Trust
SEC Form 4 Filing
Director Barbara Kahn transferred shares of Dexcom Inc. common stock from direct ownership to a trust on May 18, 2024.
Summary
- On May 18, 2024, Barbara Kahn, a director of Dexcom Inc., transferred 2,927 shares of common stock from direct ownership to a trust.
- The transfer was made to the Barbara Kahn TTEE Barbara Kahn Rev TRT DTD 6/26/96 & Robert Meyer TTEE Robert Meyer Rev Trst DTD 6/26/96 upon vesting of previously awarded restricted stock units.
- Following the transaction, Barbara Kahn directly owns 0 shares and indirectly owns 22,575 shares through the trust.
Sentiment
Score: 5
Explanation: This is a neutral transaction involving a transfer of shares to a trust, with no inherent positive or negative implications.
Industry Context
This is a routine disclosure related to insider transactions and is typical for publicly traded companies.
Key Dates
| Date | Description |
|---|---|
| 06/26/1996 | Date of Barbara Kahn Rev TRT DTD and Robert Meyer Rev Trst DTD |
| 05/18/2024 | Date of stock transfer to trust |
| 05/21/2024 | Date of Form 4 signature |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.